1. Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC). (1st January 2020) Authors: Schimanski, Carl Christoph; Kasper, Stefan; Hegewisch-Becker, Susanna; Schröder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Vöhringer, Matthias; Öllinger, Robert; Lordick, Florian; Heinemann, Volker; Geißler, Michael; Schulz-Abelius, Armin; Bernhard, Helga; Schön, Michael R.... Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC). (1st January 2020) Authors: Schimanski, Carl Christoph; Kasper, Stefan; Hegewisch-Becker, Susanna; Schröder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Vöhringer, Matthias; Öllinger, Robert; Lordick, Florian; Heinemann, Volker; Geißler, Michael; Schulz-Abelius, Armin; Bernhard, Helga; Schön, Michael R.... Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗